08 Nov Targeting SRC as a novel strategy to overcome resistance to BRAF-targeted therapy in BRAFV600E-mutated colorectal cancer.
Posted at 16:10h
in New frontiers in treatment/Precision medicine
ID: 2529
Autores: Rubio Cuesta, Beatriz (0); Rubio-Cuesta, Beatriz (1); Carretero-Puche, Carlos (1); Lamas-Paz, Arantza (1); Lens-Pardo, Alberto (1); Llamas Granda, Patricia (1); Sarmentero, Jacinto (1); Rubio-Gonzalez, Eduardo (2); Gil-Calderón, Beatriz (1); Cámara-Jurado, María (3); Salamanca, Javier (3); Antón-Pascual, Beatriz (1,4); Garcia-Carbonero, Rocio (1,4,5); Soldevilla, Beatriz (1,4,6)
Temática: New frontiers in treatment/Precision medicine
Leer completo